Paul F. Schellhammer

1.2k total citations · 1 hit paper
11 papers, 923 citations indexed

About

Paul F. Schellhammer is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Surgery. According to data from OpenAlex, Paul F. Schellhammer has authored 11 papers receiving a total of 923 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 3 papers in Rheumatology and 2 papers in Surgery. Recurrent topics in Paul F. Schellhammer's work include Prostate Cancer Diagnosis and Treatment (5 papers), Prostate Cancer Treatment and Research (5 papers) and Hormonal and reproductive studies (2 papers). Paul F. Schellhammer is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (5 papers), Prostate Cancer Treatment and Research (5 papers) and Hormonal and reproductive studies (2 papers). Paul F. Schellhammer collaborates with scholars based in United States, Belgium and Canada. Paul F. Schellhammer's co-authors include Richard P. Moriarty, George L. Wright, Daniel P. Petrylak, B. Mayer Grob, Mark S. Soloway, Roohollah Sharifi, Michael F. Sarosdy, Peter Venner, Anthony L. Patterson and Norman L. Block and has published in prestigious journals such as Cancer, International Journal of Cancer and Urology.

In The Last Decade

Paul F. Schellhammer

11 papers receiving 884 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy

1996 511 citations George L. Wright, B. Mayer Grob et al. Urology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul F. Schellhammer United States	8	712	308	182	157	109	11	923
Chu Tm United States	13	429 0.6×	152 0.5×	266 1.5×	165 1.1×	113 1.0×	32	825
R. Loor United States	9	367 0.5×	63 0.2×	237 1.3×	90 0.6×	88 0.8×	15	688
Richard P. Moriarty United States	8	476 0.7×	285 0.9×	165 0.9×	147 0.9×	86 0.8×	8	675
Masayuki Egawa Japan	14	397 0.6×	63 0.2×	326 1.8×	186 1.2×	123 1.1×	30	794
Gustavo Reynoso United States	12	205 0.3×	207 0.7×	141 0.8×	326 2.1×	128 1.2×	28	708
Papsidero Ld	7	295 0.4×	94 0.3×	144 0.8×	64 0.4×	75 0.7×	9	482
J. Leinonen Finland	11	481 0.7×	41 0.1×	185 1.0×	157 1.0×	183 1.7×	20	770
Hirofumi Kishi Japan	12	419 0.6×	332 1.1×	302 1.7×	157 1.0×	177 1.6×	19	928
Karen Gray United States	8	413 0.6×	298 1.0×	251 1.4×	174 1.1×	42 0.4×	10	737
Amarnath Challapalli United Kingdom	15	258 0.4×	368 1.2×	170 0.9×	171 1.1×	67 0.6×	59	816

Countries citing papers authored by Paul F. Schellhammer

Since Specialization

Citations

This map shows the geographic impact of Paul F. Schellhammer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul F. Schellhammer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul F. Schellhammer more than expected).

Fields of papers citing papers by Paul F. Schellhammer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul F. Schellhammer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul F. Schellhammer. The network helps show where Paul F. Schellhammer may publish in the future.

Co-authorship network of co-authors of Paul F. Schellhammer

This figure shows the co-authorship network connecting the top 25 collaborators of Paul F. Schellhammer. A scholar is included among the top collaborators of Paul F. Schellhammer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul F. Schellhammer. Paul F. Schellhammer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Yang, Ximing J., Kristen Lecksell, James E. Gottesman, et al.. (1999). Does long-term finasteride therapy affect the histologic features of benign prostatic tissue and prostate cancer on needle biopsy?. Urology. 53(4). 696–700. 67 indexed citations

2.

Somers, Kenneth D., et al.. (1998). Involvement of Shc in the signaling response of human prostate tumor cell lines to epidermal growth factor. International Journal of Cancer. 77(6). 923–927. 7 indexed citations

3.

Schellhammer, Paul F., Roohollah Sharifi, Norman L. Block, et al.. (1997). Clinical benefits of bicalutamide compared with flutamide in combined androgen blockade for patients with advanced prostatic carcinoma: Final report of a double-blind, randomized, multicenter trial. Urology. 50(3). 330–336. 123 indexed citations

4.

Schellhammer, Paul F., et al.. (1997). Additional bacillus calmette-guérin therapy for recurrent transitional cell carcinoma after an initial complete response. Urology. 49(5). 687–691. 47 indexed citations

5.

Wright, George L., et al.. (1996). Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy. Urology. 48(2). 326–334. 511 indexed citations breakdown →

6.

Soloway, Mark S., et al.. (1996). Bicalutamide in the treatment of advanced prostatic carcinoma: a phase II multicenter trial. Urology. 47(1). 33–37. 15 indexed citations

7.

Kuban, Deborah A., Anas M. El‐Mahdi, & Paul F. Schellhammer. (1995). Potential benefit of improved local tumor control in patients with prostate carcinoma. Cancer. 75(9). 2373–2382. 34 indexed citations

8.

Moriarty, Richard P., et al.. (1995). Malignant pericardial effusion as initial solitary site of metastasis from transitional cell carcinoma of the bladder. Urology. 45(2). 320–322. 22 indexed citations

9.

Schellhammer, Paul F., et al.. (1992). Failure of anticytokeratin 18 antibody to improve flow cytometric detection of bladder cancer. Cancer. 70(12). 2879–2884. 4 indexed citations

10.

Schellhammer, Paul F., et al.. (1990). Disease-related effects OF perioperative blood transfusions associated with 125I seed implantation for prostate carcinoma. Urology. 36(2). 103–106. 1 indexed citations

11.

Schellhammer, Paul F.. (1988). Radical prostatectomy Patterns of local failure and survival in 67 patients. Urology. 31(3). 191–197. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact